Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria
American Journal of Respiratory and Critical Care Medicine - United States
doi 10.1164/rccm.201602-0402oc
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
American Thoracic Society